{"organizations": [], "uuid": "a327db43b52d44dde9b999056b11fa15146b331b", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180417.html", "section_title": "Archive News &amp; Video for Tuesday, 17 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-cesca-therapeutics-announces-first/brief-cesca-therapeutics-announces-first-evaluation-agreement-with-a-leading-u-s-academic-research-institution-for-x-series-products-idUSFWN1RU0U4", "country": "US", "domain_rank": 408, "title": "BRIEF-Cesca Therapeutics Announces First Evaluation Agreement With A Leading U.S. Academic Research Institution For X-Series Products", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.005, "site_type": "news", "published": "2018-04-17T20:39:00.000+03:00", "replies_count": 0, "uuid": "a327db43b52d44dde9b999056b11fa15146b331b"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-cesca-therapeutics-announces-first/brief-cesca-therapeutics-announces-first-evaluation-agreement-with-a-leading-u-s-academic-research-institution-for-x-series-products-idUSFWN1RU0U4", "ord_in_thread": 0, "title": "BRIEF-Cesca Therapeutics Announces First Evaluation Agreement With A Leading U.S. Academic Research Institution For X-Series Products", "locations": [], "entities": {"persons": [{"name": "cesca", "sentiment": "none"}], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "cesca therapeutics inc", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 17 (Reuters) - Cesca Therapeutics Inc:\n* CESCA THERAPEUTICS ANNOUNCES FIRST EVALUATION AGREEMENT WITH A LEADING U.S. ACADEMIC RESEARCH INSTITUTION FOR X-SERIESâ„¢ PRODUCTS THAT PROVIDE AUTOMATED, CLOSED SYSTEM CELLULAR PROCESSING\n* CESCA THERAPEUTICS INC - CESCA WILL BE RESPONSIBLE FOR PROVIDING ITS X-SERIES PRODUCTS, ALONG WITH REQUIRED TRAINING AND SUPPORT Source text for Eikon: Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-17T20:39:00.000+03:00", "crawled": "2018-04-18T17:54:52.006+03:00", "highlightTitle": ""}